Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP
Referred: Emerging Issues(H)
Email me when HB 3357 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 3357. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would prohibit manufacturers and sellers in Missouri from offering intravenous solution containers and tubing that contain DEHP added on purpose. It sets compliance dates of January 1, 2030 for containers and January 1, 2035 for tubing, limits any unintentional DEHP to less than 0.1% by weight, and exempts certain blood‑collection devices. The aim is to lower patient exposure to the chemical.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 3357
3 free questions a day, no accountHistory
- Referred: Emerging Issues(H)
- Read Second Time (H)
- Introduced and Read First Time (H)
Sponsors
- Jeremy Dean · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 3357 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 3357 freeOr ask your AI assistant about HB 3357 directly:
Add to Claude, ChatGPT or Cursor